Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -11.07%202.57B | 7.30%953.78B | 1.20%268.2B | -4.22%227B | 9.47%230.79B | 29.41%227.79B | 33.98%888.87B | 19.27%265.03B | 41.29%236.99B | 45.06%210.82B |
Cost of revenue | -5.87%167.89B | -6.45%852.63B | -4.85%248.08B | -15.95%220.94B | -8.73%205.25B | 9.45%178.36B | 42.75%911.4B | 20.64%260.71B | 49.35%262.86B | 66.66%224.88B |
Gross profit | -29.85%34.68B | 548.96%101.16B | 366.20%20.13B | 123.45%6.07B | 281.71%25.54B | 278.23%49.43B | -190.23%-22.53B | -29.38%4.32B | -213.06%-25.86B | -235.11%-14.05B |
Operating expense | ||||||||||
Operating profit | -29.85%34.68B | 548.96%101.16B | 366.20%20.13B | 123.45%6.07B | 281.71%25.54B | 278.23%49.43B | -190.23%-22.53B | -29.38%4.32B | -213.06%-25.86B | -235.11%-14.05B |
Net non-operating interest income (expenses) | 1.18%-2.52B | -28.22%-12.11B | -79.32%-4.33B | -8.12%-2.6B | -13.74%-2.63B | -10.29%-2.55B | 0.53%-9.44B | -3.61%-2.41B | -0.29%-2.4B | 3.38%-2.32B |
Non-operating interest income | 833.33%28M | 17.19%75M | 55.56%28M | 375.00%19M | -34.21%25M | -25.00%3M | 220.00%64M | 125.00%18M | 0.00%4M | 850.00%38M |
Non-operating interest expense | -0.20%2.55B | 28.15%12.18B | 79.14%4.36B | 8.73%2.62B | 12.96%2.66B | 10.22%2.56B | -0.06%9.51B | 4.02%2.43B | 0.29%2.41B | -1.96%2.35B |
Net investment income | -7.77%380M | -1.00%691M | -63.89%26M | 7.36%248M | -86.11%5M | 14.76%412M | -3.32%698M | -12.20%72M | 3.59%231M | -53.85%36M |
Gain(Loss) on financial instruments designated as cash flow hedges | 476M | 0 | 90,400.00%905M | |||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -3.85%-81M | 123.61%161M | 105.47%263M | 110.78%11M | -124.82%-35M | 17.89%-78M | -77.91%72M | -69.01%128M | -700.00%-102M | 642.31%141M |
Special income (charges) | 37,422.22%10.08B | -44.76%1.88B | 243.70%1.58B | -103.64%-175M | 271.04%508M | -350.00%-27M | 473.36%3.41B | 28.65%-1.1B | 448.37%4.8B | -112.33%-297M |
Less:Other special charges | ---9.62B | -64.50%-10.62B | -527.53%-9.92B | ---433M | ---- | ---- | -909.79%-6.45B | -106.27%-1.58B | ---- | ---- |
Less:Write off | -1,796.30%-458M | 186.52%8.74B | 211.66%8.34B | 768.57%608M | -180.47%-239M | 350.00%27M | 2,551.30%3.05B | 16.25%2.68B | 138.04%70M | 112.33%297M |
Other non-operating income (expenses) | -28.45%244M | -1,168.46%-3.18B | -122.89%-3.17B | 100.46%11M | -115.65%-371M | -80.31%341M | 108.71%298M | 29.07%-1.42B | -1,053.60%-2.38B | 406.60%2.37B |
Income before tax | -8.99%43.25B | 433.12%88.6B | 2,840.77%14.5B | 113.86%3.56B | 263.05%23.01B | 272.96%47.52B | -318.11%-26.6B | -33.83%493M | -122.69%-25.72B | -245.58%-14.12B |
Income tax | -8.11%11.91B | 553.19%21.68B | 0.62%1.46B | 109.73%628M | 406.99%6.63B | 445.14%12.96B | -198.33%-4.78B | -42.86%1.45B | -112.58%-6.45B | -224.01%-2.16B |
Net income | -9.32%31.34B | 406.81%66.92B | 1,458.02%13.04B | 115.24%2.94B | 237.04%16.39B | 233.46%34.56B | -397.57%-21.81B | 46.61%-960M | -126.27%-19.26B | -250.31%-11.96B |
Net income continuous operations | -9.32%31.34B | 406.79%66.92B | 1,457.92%13.04B | 115.24%2.94B | 237.05%16.39B | 233.47%34.56B | -397.59%-21.81B | 46.61%-960M | -126.29%-19.26B | -250.30%-11.96B |
Noncontrolling interests | 339.02%98M | 89.21%719M | 118.50%496M | 131.34%310M | -150.00%-46M | 43.84%-41M | -18.28%380M | 141.49%227M | -37.09%134M | -29.23%92M |
Net income attributable to the company | -9.71%31.25B | 398.30%66.2B | 1,155.56%12.54B | 113.53%2.62B | 236.37%16.43B | 231.53%34.61B | -423.32%-22.19B | 37.21%-1.19B | -122.27%-19.39B | -253.99%-12.05B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -9.71%31.25B | 398.30%66.2B | 1,155.56%12.54B | 113.53%2.62B | 236.37%16.43B | 231.53%34.61B | -423.32%-22.19B | 37.21%-1.19B | -122.27%-19.39B | -253.99%-12.05B |
Gross dividend payment | ||||||||||
Basic earnings per share | -9.78%150.48 | 374.39%315.44 | 894.91%59.38 | 111.49%11.05 | 229.46%78.22 | 239.49%166.79 | -532.67%-114.96 | 31.53%-7.47 | -117.50%-96.2 | -266.03%-60.42 |
Diluted earnings per share | -9.78%150.48 | 374.39%315.44 | 894.91%59.38 | 111.49%11.05 | 229.46%78.22 | 239.49%166.79 | -532.67%-114.96 | 31.53%-7.47 | -117.50%-96.2 | -266.03%-60.42 |
Dividend per share | 0 | 20 | 15 | 0 | 5 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |